4REGN
Regeneron Pharmaceuticals, Inc. · EUROTLX:4REGN
863.20 EUR44.30 +5.41%
Regeneron Pharmaceuticals, Inc. (EUROTLX:4REGN) last traded at 863.20 EUR, up 5.41% on the day. Over the past year the stock is up 52.08%. Its 52-week range is 514.00 to 863.20. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open863.20
Day range863.20 – 863.20
52-week range514.00 – 863.20
Volume0
Average volume (10 days)0
Market cap (USD)95.51 B
P/E21.59
EPS (TTM) (USD)45.30
Dividend yield0.40%
Beta (1 year)0.1075
Revenue (TTM) (USD)16.90 B
Employees15.41 K
Performance
+20.76%1 week
+32.78%1 month
+31.15%3 months
+40.79%6 months
+30.47%Year to date
+52.08%1 year
Technical reading
Strongly bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Regeneron Pharma Price Target Raised to $855.00/Share From $779.00 by Morgan StanleyDow Jones Newswires · 02 Nov 2026
- Morgan Stanley maintains Regeneron Pharmaceuticals at Equal-Weight, raises price target to $855 from $779TradingView · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $913.00/Share From $810.00 by RBC CapitalDow Jones Newswires · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $982.00/Share From $780.00 by Truist SecuritiesDow Jones Newswires · 02 Nov 2026
- Truist Securities maintains Regeneron Pharmaceuticals at Buy, raises price target to $982 from $780TradingView · 02 Nov 2026
- RBC Capital maintains Regeneron Pharmaceuticals at Sector Perform, raises price target to $913 from $810TradingView · 02 Nov 2026
- Regeneron Pharma Is Maintained at Buy by GuggenheimDow Jones Newswires · 02 Nov 2026
- Guggenheim maintains Regeneron Pharmaceuticals at Buy, raises price target to $1100 from $1030TradingView · 02 Nov 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.